Pre-made Ponsegromab benchmark antibody ( Whole mAb, anti-GDF15 therapeutic antibody, Anti-GDF-15/MIC-1/MIC1/NAG-1/PDF/PLAB/PTGFB Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-451

Pre-Made Ponsegromab biosimilar, Whole mAb, Anti-GDF15 Antibody: Anti-GDF-15/MIC-1/MIC1/NAG-1/PDF/PLAB/PTGFB therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Ponsegromab (formerly PF 06946860) is a subcutaneously administered, growth factor inhibitor, being developed by Pfizer, for the treatment of cachexia.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package List Price(In USD) Discount off Discount Price
GMP-Bios-ab-451-1mg 1mg 3090 30% 2163

Size: 1mg | 10mg | 100mg



Description

Products Name (INN Index) Pre-Made Ponsegromab biosimilar, Whole mAb, Anti-GDF15 Antibody: Anti-GDF-15/MIC-1/MIC1/NAG-1/PDF/PLAB/PTGFB therapeutic antibody
INN Name Ponsegromab
TargetGDF15
FormatWhole mAb
Derivation
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-I
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2020
Year Recommendedna
CompaniesPfizer
Conditions Approvedna
Conditions Activena
Conditions Discontinuedna
Development Techna